Pan-Neurofascin Nodo-Paranodopathy Presenting as Fulminant Guillain-Barre Syndrome
Neurol 105:e213848, Cabral,A.,et al, 2025
Expanding Clinical Spectrum an Anti-GQ1b Antibody Syndrome, A Review
JAMA Neurol 81:762-770, Lee,S-U.,et al, 2024
Acute Onset of Diplopia in Pregnancy
Neurol 91:e180-e184, Munro, Z. & Fernandez, D., 2018
A 35-year-old Woman with Diplopia, Ataxia, and Altered Mental Status
Neurol 91:e1942-e1946, Bauer, Z.,et al, 2018
Paraparetic Guillain-Barre Syndrome
Neurol 82:1984-1989, Van Den Berg, B.,et al, 2014
Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012
Recognizing Guillain-Barr� Syndrome in Preschool Children
Neurol 76:807-810, Roodbol,J.,et al, 2011
Guillain-Barre Syndrome
BMJ 337:227-231, Winer,J.B., 2008
Intravenous Immunoglobulin Therapy for Miller Fisher Syndrome
Neurol 68:1144-1146, Mori,M.,et al, 2007
Pediatric Encephalitis: What Is the Role of Mycoplasma Pneumoniae
Pediatrics 120:305-313, Christie,L.J., et al, 2007
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Subacute Inflammatory Demyelinating Polyneuropathy
Neurol 61:1507-1512, Oh,S.J.,et al, 2003
Mycoplasma Pneumoniae Encephalitis in Childhood
J Microbiol Immunol Infect 35:173-178, Lin,W.-C., et al, 2002
Mild Guillain-Barre Syndrome
Arch Neurol 58:1098-1101, Green,D.M. &Ropper,A.H., 2001
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Secondary Hyperkalaemic Paralysis
JNNP 64:249-252, Evers,S.,et al, 1998
Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998
Pain in Guillain-Barre Syndrome
Neurol 48:328-331, Moulin,D.E.,et al, 1997
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Idiopathic Autonomic Neuropathy:Clinical Neurophysiologic, and Follow-up Studies on 27 Patients
Neurol 44:1675-1682, Suarez,G.A.,et al, 1994
Autonomic Involvement in Guillain-Barre Syndrome:A Review
Muscle & Nerve 17:1145-1155994., Zochodne,D.W., 1994
Acute Neuromuscular Respiratory Paralysis
JNNP 56:334-343, Hughes,R.A.C.&Bihari,D., 1993
Relapse in Guillain-Barre Syndrome after Treatment with Human Immune Globulin
Neurol 43:872-875, 8571993., Inrani,D.N.,et al, 1993
Human Immune Globulin Infusion in Guillain-Barre Syndrome:Worsening During & After Treatment
Neurol 43:1034-1036, 8571993., Castro,L.H.M.&Ropper,A.H., 1993
Intensive Management and Treatment of Severe Guillain-Barre Syndrome
Crit Care Med 21:433-446, Hund,E.F.,et al, 1993
Plasmapheresis in Children with Guillain-Barre Syndrome
Neurol 41:1928-1931, Lamont,P.J.,et al, 1991
Limited Relapse in Guillain-Barre Syndrome after Plasma Exchange
Arch Neurol 45:314-315, Ropper,A.H.,et al, 1988
Cardiovascular Autonomic Dysfunction in Guillain-Barre Syndrome, Therapeutic Implications of Swan-Ganz Monitoring
Arch Neurol 45:115-117, Dalos,N.P.,et al, 1988
Plasmapheresis and Guillain-Barre Syndrome:Analysis of Prognostic Factors & the Effect of Plasmapheresis
Ann Neurol 23:347-353, McKhann,G.M.,et al, 1988
A 56-Year-Old Woman with New-Onset Hoarsement and Dysphagia
Neurol 104:e213363, McAree,M. & Frontera, J.A., 2025
An 8-Year-Old with Acute Onset Ataxia
Neurol 99:305-310, McLaren, J.R.,et al, 2022
Acute demyelinating polyneuropathy induced by nivolumab
JNNP 89:435-437, Fukumoto, Y.,et al, 2018
Zika Virus
NEJM 374:1552-1563, Petersen, L.R.,et al, 2016
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016
Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Lyme Disease (Erythema Chronicum Migrans; Borreliosis
Adams & Victors Principles of Neurology, Chp 32, pg 728, Ropper, A.H.,et al, 2014
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
Antibiotic Responsive Demyelinating Neuropathy Related to Lyme Disease
Neurol 72:1786-1787, Muley, S.A.,et al, 2009
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
Supportive Care for Patients With Guillain-Barr Syndrome
Arch Neurol 62:1194-1198, Hughes,R.A.C.,et al, 2005
Anticipating Mechanical Ventilation in Guillain-Barre Syndrome
Arch Neurol 58:893-898,871, Lawn,N.D.,et al, 2001
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Tracheostomy, In Guillain- Barre Syndrome
Muscle & Nerve 22:1058-1062, Lawn,N.D.&Wijdicks,E.F.M., 1999
Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Respiratory Management in Acute Neurologic Illness
Neurol 50:11-20, Wijdicks,E.F.M.&Borel,C.O., 1998